by MM360 Staff | May 26, 2025 | Myeloma News
Source: Pharmacy Times articles A panelist discusses recent advancements in the respiratory syncytial virus (RSV) vaccine space, including the approval of Arexvy and Abrysvo for older adults and pregnant individuals, the development of promising mRNA and protein...
by MM360 Staff | May 26, 2025 | Myeloma News
Source: Pharmacy Times articles A panelist discusses key insights for pharmacists to prioritize, including staying informed about new respiratory syncytial virus (RSV) vaccines such as Arexvy and Abrysvo, educating patients on the benefits of vaccination, monitoring...
by MM360 Staff | May 25, 2025 | Uncategorized
Source: CureToday articles IDH inhibitors, now FDA approved for lower-grade gliomas, yield fewer side effects than chemotherapy, said Dr. Ryan Merrell. Read More
by MM360 Staff | May 25, 2025 | Uncategorized
Source: CureToday articles Maria, my oncology nurse, inspired lasting change in my life through compassion, wisdom and faith during my cancer surgery and recovery. Read More
by MM360 Staff | May 24, 2025 | Uncategorized
Source: CureToday articles Kathleen Shuey, M.S., RN, SCON, ACNS-BC, listens and guides us in the right direction in caring for our oncology population. Read More
